Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine versus bupivacaine + dexamethasone TAP block after cesarean section
ChiCTR2400091060Phase 4Not yet recruiting
- Sponsor
- Department of Anesthesiology, General Hospital of Xinjiang Military Region
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine, bupivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Department of Anesthesiology, General Hospital of Xinjiang Military Region. Primary endpoint: VAS score 24 hours after operation. Planned start Oct 2024; status: not yet recruiting.
02
Drugs
liposomal bupivacainebupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400091060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091060.